002262 Share Price Performance
CN¥0
-24.72 (-100.00%)
Price CN¥0
Share Pricen/a
Jiangsu Nhwa Pharmaceutical Co., LTD Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
002262 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Jiangsu Nhwa Pharmaceutical Co., LTD Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 1.21
- 74.61%
- 20.41%
- 0.003%
About 002262
- Founded
- 1978
- Employees
- 5923
- CEO
- WebsiteView website
Jiangsu Nhwa Pharmaceutical Co., LTD engages in production, marketing, and services related to central nervous system drugs in China. The company offers Duloxetine Hcl, Risperidone, Ziprasidone Hcl, Etomidate Fat Emulsion, Gabapentin, Zaleplon, etc., as well as Iptakalim, an anti-hypertension drug. It also provides penehyquinac acid hydrochloride injection, sufentanil citrate injection, oxeridine fumarate, injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, duloxetine hydrochloride enteric dissolving capsules, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, pregabalin capsules, lacosamide, injection, mivacuride injection, etc. The company’s products are used for treatment of anesthesiology, psychiatry and neurology, as well as APIs. Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is headquartered in Xuzhou, China.
